Sterility Testing Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Sterility Testing Market: By Product Type (Instruments, Kits and Reagents, and Services), By Test Type (Membrane Filtration, Direct Inoculation, and Other Sterility Tests), By Application (Pharmaceutical and Biological Manufacturing, Medical Devices Manufacturing, and Other Applications), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Sterility Testing Market Size is anticipated to be valued at USD 972.6 Million in 2021 and is expanded to grow at a significant CAGR of 10.9% over 2022-2028. Sterility testing is a critical aspect of GMP microbiology testing for sterile pharmaceuticals, medical equipment, and materials to verify their safety. During the sterilization validation procedure, as well as for routine release testing, sterility testing is essential. Stringent government regulations and an increased number of drug launches are boosting the growth of the global sterility testing market. For instance, the FDA issues a final rule on sterility testing of biological products, providing greater flexibility for developing sterility test methods. Furthermore, specific safety concerns associated with the products, which generally arise from the manufacturing process and rising demand for the sterility of the products, are driving the global sterility testing market. Increased pharmaceutical outsourcing creates opportunities for the key market players. Based on product type reagent and kits segment holds the largest share. The growth of this segment is due to the availability of a wide range of products that helps in minimizing the risk of false-negative and false-positive results. The growing demand for reagents and kits is also expected to drive the growth of this segment. Based on application, pharmaceutical and biological manufacturing recorded the highest share in 2021.

Recent Market Developments:

In June 2021, Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion.

In November 2020, the life science company Sartorius successfully closed the acquisition of the Slovenian purification specialist BIA Separations.

Sterility Testing Market

MARKET SUMMARY
-
10.9%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 10.9%
  • Largest Market– North-America
  • Fastest Growing Market– Asia-Pacific

Sterility Testing Market

  • The sterility testing market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The sterility testing market is segmented based on product type, test type, end-user, and geography.
Key Players
  • LexaMed
  • Sartorius AG
  • Neopharm Labs Inc.
  • Danaher Corporation
  • Pace Analytical Services, Inc.
Sterility Testing Market

Dynamics

The growth of Pharmaceutical and biotechnology companies is driving the development of the sterility testing market. In pharmaceutical and biotechnology companies’ sterility testing is carried out at all levels of manufacturing to minimize the risk of product contamination. Subsequently, the growth of this industry in the coming years will considerably boost the overall sterility testing market. The global sterility testing market is constrained by high levels of consolidation and tight regulatory bodies and policies.


North-America Got Significant Share

Sterility Testing Market

Because of increased drug launches and higher expenditure in research & development, North America held the largest share of the worldwide sterility testing market. Furthermore, increasing government support for pharmaceutical and biotechnology industries and rising demand for sterilized products are the factors escalating the sterility testing market in North America. The market in Asia-Pacific is projected to be the fastest-growing at a CAGR of XX % from 2022 to 2028, owing to multiplying outlay on life science research.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Sterility Testing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The Sterility Testing Market is projected to expand at a CAGR of 10.9% during the forecast period.

Neopharm Labs Inc., LexaMed, Danaher Corporation, Sartorius AG, Pace Analytical Services, Inc.

Asia-Pacific is the fastest-growing region for Sterility Testing Market


Report

Company Profile

  • Merck KGaA
  • Baxter
  • Boston Analytical
  • Neopharm Labs Inc.
  • LexaMed
  • Danaher Corporation
  • Sartorius AG
  • Pace Analytical Services, Inc.
  • Pacific Biolabs
  • Thermo Fisher Scientific Inc.
  • Wuxi Apptec
  • Rapid Micro Biosystems, Inc.

Description

Sterility Testing Market Size is anticipated to be valued at USD 972.6 Million in 2021 and is expanded to grow at a significant CAGR of 10.9% over 2022-2028. Sterility testing is a critical aspect of GMP microbiology testing for sterile pharmaceuticals, medical equipment, and materials to verify their safety. During the sterilization validation procedure, as well as for routine release testing, sterility testing is essential. Stringent government regulations and an increased number of drug launches are boosting the growth of the global sterility testing market. For instance, the FDA issues a final rule on sterility testing of biological products, providing greater flexibility for developing sterility test methods. Furthermore, specific safety concerns associated with the products, which generally arise from the manufacturing process and rising demand for the sterility of the products, are driving the global sterility testing market. Increased pharmaceutical outsourcing creates opportunities for the key market players. Based on product type reagent and kits segment holds the largest share. The growth of this segment is due to the availability of a wide range of products that helps in minimizing the risk of false-negative and false-positive results. The growing demand for reagents and kits is also expected to drive the growth of this segment. Based on application, pharmaceutical and biological manufacturing recorded the highest share in 2021.

Recent Market Developments:

In June 2021, Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion.

In November 2020, the life science company Sartorius successfully closed the acquisition of the Slovenian purification specialist BIA Separations.

Reviews

There are no reviews yet.

Be the first to review “Sterility Testing Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX